Wellington Management Co’s Top Holdings in the Healthcare Sector

Wall St. Watchdog reveals information about Wellington Management Co’s top holdings in the Healthcare sector.

  • Merck & Co. Inc. (NYSE:MRK): On 3/31/11 Wellington Management Co. reported holding 99,770,787 shares with a market value of $3,293,433,511. This comprised 1.17% of the total portfolio. On 6/30/11, Wellington Management Co. held 112,489,651 shares with a market value of $3,969,759,887. This comprised 1.43% of the total portfolio. The net change in shares for this position over the two quarters is 12,718,864. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products.  Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Pfizer, Inc. (NYSE:PFE): On 3/31/11 Wellington Management Co. reported holding 251,626,826 shares with a market value of $5,110,540,702. This comprised 1.82% of the total portfolio. On 6/30/11, Wellington Management Co. held 184,422,994 shares with a market value of $3,799,113,747. This comprised 1.36% of the total portfolio. The net change in shares for this position over the two quarters is -67,203,832. About the company: Pfizer, Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals.  The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • UnitedHealth Group, Inc. (NYSE:UNH): On 3/31/11 Wellington Management Co. reported holding 77,225,190 shares with a market value of $3,490,578,647. This comprised 1.24% of the total portfolio. On 6/30/11, Wellington Management Co. held 62,115,215 shares with a market value of $3,203,902,903. This comprised 1.15% of the total portfolio. The net change in shares for this position over the two quarters is -15,109,975. About the company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Johnson & Johnson, Inc. (NYSE:JNJ): On 3/31/11 Wellington Management Co. reported holding 31,042,335 shares with a market value of $1,839,258,349. This comprised 0.66% of the total portfolio. On 6/30/11, Wellington Management Co. held 32,479,176 shares with a market value of $2,160,514,678. This comprised 0.78% of the total portfolio. The net change in shares for this position over the two quarters is 1,436,841. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Eli Lilly & Co. (NYSE:LLY): On 3/31/11 Wellington Management Co. reported holding 49,248,249 shares with a market value of $1,732,060,827. This comprised 0.62% of the total portfolio. On 6/30/11, Wellington Management Co. held 50,568,324 shares with a market value of $1,897,829,138. This comprised 0.68% of the total portfolio. The net change in shares for this position over the two quarters is 1,320,075. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 3/31/11 Wellington Management Co. reported holding 37,505,634 shares with a market value of $1,881,657,589. This comprised 0.67% of the total portfolio. On 6/30/11, Wellington Management Co. held 38,011,870 shares with a market value of $1,832,932,418. This comprised 0.66% of the total portfolio. The net change in shares for this position over the two quarters is 506,236. About the company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Medtronic, Inc. (NYSE:MDT): On 3/31/11 Wellington Management Co. reported holding 43,786,589 shares with a market value of $1,723,002,210. This comprised 0.61% of the total portfolio. On 6/30/11, Wellington Management Co. held 47,173,179 shares with a market value of $1,817,582,529. This comprised 0.65% of the total portfolio. The net change in shares for this position over the two quarters is 3,386,590. About the company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Amgen, Inc. (NASDAQ:AMGN): On 3/31/11 Wellington Management Co. reported holding 27,603,301 shares with a market value of $1,475,396,460. This comprised 0.53% of the total portfolio. On 6/30/11, Wellington Management Co. held 30,264,051 shares with a market value of $1,765,907,330. This comprised 0.63% of the total portfolio. The net change in shares for this position over the two quarters is 2,660,750. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Cardinal Health, Inc. (NYSE:CAH): On 3/31/11 Wellington Management Co. reported holding 35,449,726 shares with a market value of $1,458,047,268. This comprised 0.52% of the total portfolio. On 6/30/11, Wellington Management Co. held 36,565,829 shares with a market value of $1,660,819,886. This comprised 0.60% of the total portfolio. The net change in shares for this position over the two quarters is 1,116,103. About the company: Cardinal Health, Inc. provides complementary products and services to healthcare providers and manufacturers. The Company’s services include pharmaceutical distribution, health-care product manufacturing, distribution and consulting services, drug delivery systems development, pharmaceutical packaging, automated dispensing systems manufacturing, and retail pharmacy franchising.
  • CVS Caremark Corporation (NYSE:CVS): On 3/31/11 Wellington Management Co. reported holding 41,009,541 shares with a market value of $1,407,447,435. This comprised 0.50% of the total portfolio. On 6/30/11, Wellington Management Co. held 43,703,314 shares with a market value of $1,642,370,620. This comprised 0.59% of the total portfolio. The net change in shares for this position over the two quarters is 2,693,773. About the company: CVS Caremark Corporation is an integrated pharmacy health care provider. The Company’s offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico.

(Note: Data about Wellington Management Co’s stock holdings are sourced from whalewisdom.com.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>